Resistance mechanism to fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma.
Cancer Treat Rev
; 121: 102627, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-37925878
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bile Duct Neoplasms
/
Cholangiocarcinoma
Limits:
Humans
Language:
En
Journal:
Cancer Treat Rev
Year:
2023
Document type:
Article